In the last trading session, 1.56 million Atyr Pharma Inc (NASDAQ:ATYR) shares changed hands as the company’s beta touched 0.79. With the company’s per share price at $3.27 changed hands at -$0.08 or -2.39% during last session, the market valuation stood at $290.57M. ATYR’s last price was a discount, traded about -42.51% off its 52-week high of $4.66. The share price had its 52-week low at $1.42, which suggests the last value was 56.57% up since then. When we look at Atyr Pharma Inc’s average trading volume, we note the 10-day average is 1.05 million shares, with the 3-month average coming to 1.42 million.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Instantly ATYR was in red as seen at the end of in last trading. With action -0.30%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -9.67%, with the 5-day performance at -0.30% in the red. However, in the 30-day time frame, Atyr Pharma Inc (NASDAQ:ATYR) is 0.31% up. Looking at the short shares, we see there were 10.03 million shares sold at short interest cover period of 7.01 days.
Atyr Pharma Inc (ATYR) estimates and forecasts
Year-over-year growth is forecast to reach 751.06% up from the last financial year.
The company’s revenue for the corresponding quarters a year ago was 235k. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -100.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 34.28%. The 2025 estimates are for Atyr Pharma Inc earnings to increase by 17.86%.
ATYR Dividends
Atyr Pharma Inc is expected to release its next quarterly earnings report on 2025-Mar-12.
Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.24% of Atyr Pharma Inc shares while 61.91% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 63.33%.
Among Mutual Funds, the top two as of Jan 31, 2025 were Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund and Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund . With 7.85 shares estimated at $25.67 million under it, the former controlled 8.83% of total outstanding shares. On the other hand, Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund held about 7.45% of the shares, roughly 6.62 shares worth around $21.65 million.
